Table 3 Association of serum testosterone level and metabolic syndrome stratified by menopausal status
From: The association between serum testosterone levels and metabolic syndrome among women
Serum testosterone level (ng/mL) | Postmenopausal | Premenopausal | ||||||
|---|---|---|---|---|---|---|---|---|
Unadjusted | Adjusteda | Unadjusted | Adjusted | |||||
OR [95CI]b | Pc | OR [95CI] | P | OR [95CI] | P | OR [95CI] | P | |
Metabolic syndrome | ||||||||
Q1 (< 12.99) | Ref | Ref | Ref | Ref | ||||
Q2 (12.99–19.38) | 0.743 [0.537–1.029] | 0.689 [0.486–0.977] | 0.05 | 0.678 [0.416–1.107] | 0.739 [0.417–1.309] | |||
Q3 (19.39–28.38) | 0.787 [0.552–1.122] | 0.701 [0.480–1.023] | 0.408 [0.249–0.670] | 0.001 | 0.439 [0.248–0.779] | 0.01 | ||
Q4 (≥ 28.40) | 0.655 [0.443–0.970] | 0.05 | 0.606 [0.399–0.922] | 0.05 | 0.394 [0.243–0.640] | 0.001 | 0.464 [0.261–0.825] | 0.01 |
Elevated waist circumference (> 88 cm) | ||||||||
Q1 (< 12.99) | Ref | Ref | Ref | Ref | ||||
Q2 (12.99–19.38) | 1.010 [0.698–1.462] | 0.982 [0.558–1.728] | 0.733 [0.464–1.156] | 0.823 [0.367–1.843] | ||||
Q3 (19.39–28.38) | 1.144 [0.756–1.729] | 0.809 [0.422–1.552] | 0.704 [0.454–1.092] | 0.919 [0.411–2.054] | ||||
Q4 (≥ 28.40) | 1.188 [0.756–1.867] | 1.108 [0.552–2.223] | 0.695 [0.452–1.070] | 0.916 [0.409–2.050] | ||||
Elevated serum triglycerides (≥ 150 mg/dL) | ||||||||
Q1 (< 12.99) | Ref | Ref | Ref | Ref | ||||
Q2 (12.99–19.38) | 0.755 [0.547–1.043] | 0.679 [0.485–0.952] | 0.05 | 0.657 [0.408–1.058] | 0.672 [0.404–1.120] | |||
Q3 (19.39–28.38) | 0.631 [0.441–0.904] | 0.05 | 0.581 [0.399–0.845] | 0.01 | 0.486 [0.304–0.777] | 0.01 | 0.560 [0.338–0.928] | 0.05 |
Q4 (≥ 28.40) | 0.368 [0.240–0.563] | 0.01 | 0.381 [0.244–0.592] | 0.001 | 0.499 [0.316–0.789] | 0.01 | 0.622 [0.376–1.030] | |
Reduced HDL-C (< 50 mg/dL) | ||||||||
Q1 (< 12.99) | Ref | Ref | Ref | Ref | ||||
Q2 (12.99–19.38) | 0.724 [0.514–1.017] | 0.656 [0.459–0.938] | 0.05 | 0.733 [0.471–1.142] | 0.815 [0.503–1.322] | |||
Q3 (19.39–28.38) | 0.854 [0.592–1.231] | 0.788 [0.538–1.153] | 0.559 [0.363–0.859] | 0.01 | 0.497 [0.309–0.801] | 0.01 | ||
Q4 (≥ 28.40) | 0.613 [0.403–0.930] | 0.05 | 0.620 [0.401–0.959] | 0.05 | 0.531 [0.347–0.810] | 0.01 | 0.442 [0.273–0.714] | 0.001 |
Elevated serum glucose level (≥ 110 mg/dL) | ||||||||
Q1 (< 12.99) | Ref | Ref | Ref | Ref | ||||
Q2 (12.99–19.38) | 0.839 [0.611–1.152] | 0.926 [0.663–1.293] | 0.928 [0.522–1.651] | 0.962 [0.526–1.757] | ||||
Q3 (19.39–28.38) | 0.803 [0.568–1.137] | 0.831 [0.576–1.199] | 0.692 [0.391–1.226] | 0.890 [0.486–1.631] | ||||
Q4 (≥ 28.40) | 0.989 [0.679–1.439] | 0.829 [0.557–1.234] | 0.510 [0.285–0.913] | 0.05 | 0.793 [0.422–1.489] | |||